[ Theranica raises $6M in Series A ]
Theranica has raised $6 million in Series A funding.
Founded in 2016, Theranica deploys advanced electronics and wireless communication technologies, combined with recent advancements in the research of neurology, to develop a line of “electroceuticals” – drug-free solutions for a few medical conditions, starting with migraine.
The new financing will be used to complete the regulatory process of Theranica’s first product for acute treatment of migraine and to bring the product to mass production.
|Founder / CEO||Alon Ironi|
|Investors||Lightspeed Venture Partners|
|Corundum Open Innovations|
|Previous Investors||Shimon Eckhouse|